Response to ASX Price Query

Emyria Limited has responded to the ASX Price Query, stating that they are not aware of any undisclosed information that could explain recent trading in their securities. The Company notes media speculation about potential policy shifts favoring psychedelic therapies, which may have contributed to increased interest in their securities. In their recent cash flow report, Emyria disclosed anticipating an R&D Tax Incentive refund. They confirm compliance with ASX Listing Rules and that responses have been authorized as per their disclosure policy. Emyria is open to any questions or clarifications from investors regarding the market activity. If investors have further inquiries or require additional information, they are encouraged to reach out to the Company for transparency and clarification.